-
1
Potentiating intratumoral therapy with immune checkpoint inhibitors: shifting the paradigm of multimodality therapeutics
Published 2025-03-01Subjects: Get full text
Article -
2
Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal
Published 2024-11-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
3
Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trialResearch in context
Published 2025-01-01Subjects: “…Checkpoint inhibitors…”
Get full text
Article -
4
Characteristics, Incidence, and Management of Immune Checkpoint Inhibitors Related Cardiovascular Adverse Events in Real-World Practice-A Retrospective Study in Chinese Han Populat...
Published 2025-02-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
5
Increased PD-1 expression in livers associated with PD-1-antibody-induced hepatotoxicity
Published 2025-01-01Subjects: “…Checkpoint inhibitors…”
Get full text
Article -
6
Acute kidney injury in patients treated with immune checkpoint inhibitors: a single-center retrospective study
Published 2024-12-01Subjects: Get full text
Article -
7
Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
Published 2021-12-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
8
Immune checkpoint inhibitor‐related type 1 diabetes incidence, risk, and survival association
Published 2025-02-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
9
Resistance mechanisms to immune checkpoint inhibitors: updated insights
Published 2025-01-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
10
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
11
Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
Published 2025-01-01Subjects: Get full text
Article -
12
Hepatitis associated with immune checkpoint inhibitors-based combinations of other therapies: A real-world pharmacovigilance analysis based on the FDA adverse event reporting syste...
Published 2024-11-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
13
-
14
Selecting first-line immunotherapy in advanced melanoma: Current evidence on efficacy across diverse patient populations
Published 2025-01-01Subjects: Get full text
Article -
15
Sintilimab for the treatment of lung adenocarcinoma-induced immune-related hypophysitis: a case report
Published 2025-01-01Subjects: Get full text
Article -
16
Progress in immunotherapy for brain metastatic melanoma
Published 2025-01-01Subjects: Get full text
Article -
17
Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort study
Published 2025-02-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
18
PD-L1 positive platelets mediate resistance to immune checkpoint inhibitors in patients with colorectal cancer
Published 2025-01-01Subjects: Get full text
Article -
19
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment
Published 2025-01-01Subjects: Get full text
Article -
20
Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma
Published 2025-02-01Subjects: Get full text
Article